
Writer
Kirti Kumbhar
M. Pharm QA
Kirti Kumbhar is an M.Pharm graduate with experience in Quality Assurance at Lupin Limited and a strong interest in clinical research, regulatory affairs, and Trial Master File (TMF) management. She has developed knowledge of regulatory documentation, quality systems, compliance, and healthcare research through her professional experience. Passionate about clinical development and continuous learning, Kirti is committed to supporting high-quality healthcare documentation, regulatory excellence, and research-driven healthcare advancements.
109
Articles written or reviewed
About Kirti
Kirti Kumbhar (M. Pharm QA) is a writer at Pharmacally, with 109 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Kirti Kumbhar
Health TidingsNovartis Shows Durable Rhapsido Efficacy Across Three Urticaria Subtypes
Health TidingsViiV Shows Positive Real-World Results for Long-Acting HIV Treatments
Clinical Trialsargenx Meets Phase III Endpoint With Efgartigimod in Autoimmune Myositis
Clinical TrialsIpsen Reports 85.3% ALP Normalization With IQIRVO in PBC
Clinical TrialsIncyte Reports Positive Results for Povorcitinib in Vitiligo Trials
New Drug ApprovalMHRA Conditionally Authorises Ultragenyx’s Dojolvi for LC-FAOD
New Drug ApprovalSun’s ILUMYA Gains New FDA Indication Following INSPIRE Trials
Health TidingsGenmab Reports Significant Survival Benefit in LiGeR-HN1 Trial
Clinical TrialsBeam’s BEAM-301 Shows Early Metabolic Benefits in GSDIaOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala